GLP-1 clinical trials in Missouri: 22 recruiting now
28 sites in 8 Missouri cities. Registry checked October 16, 2026.
Screening for a study can take weeks. Two cash programs to check.
No insurance needed.
- SnagRxSponsored$99 a monthcompounded semaglutideCheck price →SnagRx's homepage shows its 12-month prepaid prices first
- MedviSponsored$299 a monthFirst month $179compounded semaglutideCheck price →Straight to MEDVi's GLP-1 sign-up
Weight-loss studies (8)
Weight-loss study of cagrisema
Where: Chesterfield and St Louis
What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lose weight.
Free to join
Who can join: Adults 18+ with obesity, BMI 35+.
Study record on ClinicalTrials.gov
Clinical Research Professionals, Chesterfield
Amicis Centers of Clinical Research, St Louis
Weight-loss study of orforglipron
Where: St Louis
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.
Free to join
Who can join: Children and teens 6 to 17 with obesity.
Call the site: 314-567-3377Study record on ClinicalTrials.gov
Sundance Clinical Research, St Louis. 314-567-3377
Weight-loss study of orforglipron
Where: St Louis
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.
Free to join
Who can join: Children and teens 12 to 17 with obesity.
Study record on ClinicalTrials.gov
Sundance Clinical Research, St Louis
Show 5 more studies
Weight-loss study of semaglutide
Where: St Louis
What: Tests whether a GLP-1 medicine from Novo Nordisk, semaglutide, can help people lose weight.
Free to join
Who can join: Adults 18+ who are overweight.
Study record on ClinicalTrials.gov
Amicis Centers of Clinical Research, St Louis
Weight-loss study of semaglutide
Where: City of Saint Peters
What: Tests whether a GLP-1 medicine from Novo Nordisk, semaglutide, can help people lose weight.
Free to join
Who can join: Adults 18+ who are overweight, BMI 27+.
Study record on ClinicalTrials.gov
StudyMetrix Research LLC, City of Saint Peters
Weight-loss study of tirzepatide
Where: Chesterfield
What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people with obesity lose weight.
Free to join
Who can join: Adults 18+ with obesity.
Study record on ClinicalTrials.gov
Clinical Research Professionals, Chesterfield
Weight-loss study of LY3305677
Where: City of Saint Peters and Springfield
What: Tests whether an investigational medicine from Lilly, LY3305677, can help people lose weight.
Free to join
Who can join: Adults 18 to 75 with obesity, BMI 27+.
Call the site: 636-387-5100Study record on ClinicalTrials.gov
StudyMetrix Research, City of Saint Peters. 636-387-5100
Clinvest Headlands Llc, Springfield
Weight-loss study of semaglutide
Where: St Louis
What: Tests whether a GLP-1 medicine, semaglutide, can help people lose weight.
Free to join
Who can join: Adults 50 to 75 with obesity, BMI 30+.
Call the site: 314-273-1879Study record on ClinicalTrials.gov
Washington University School of Medicine, St Louis. 314-273-1879
Type 2 diabetes studies (3)
Type 2 diabetes study of semaglutide
Where: Jefferson City and Kansas City
What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18+ with type 2 diabetes, BMI 23+.
Study record on ClinicalTrials.gov
Research Site, Jefferson City
Research Site, Kansas City
Type 2 diabetes study of survodutide
Where: City of Saint Peters
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18+ with type 2 diabetes, BMI 23+.
Call the site: 833-602-2368Study record on ClinicalTrials.gov
StudyMetrix Research, LLC, City of Saint Peters. 833-602-2368
Type 2 diabetes study of NNC0662-0419
Where: Springfield
What: Tests whether an investigational medicine from Novo Nordisk, NNC0662-0419, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18 to 75 with type 2 diabetes.
Study record on ClinicalTrials.gov
Headlands Research, Springfield
Other GLP-1 studies in Missouri (11)
Fatty liver disease with liver scarring study of survodutide
Where: Chesterfield, Columbia and Kansas City
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).
Call the site: 833-602-2368Study record on ClinicalTrials.gov
Clinical Research Professionals, Chesterfield. 833-602-2368
ObjectiveHealth-GI Associates Research, Columbia. 833-602-2368
Kansas City Research Institute, Kansas City. 833-602-2368
Fatty liver disease (also called MASH or NASH) study of survodutide
Where: Columbia and Kansas City
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.
Call the site: 833-602-2368Study record on ClinicalTrials.gov
ObjectiveHealth-GI Associates Research, Columbia. 833-602-2368
Kansas City Research Institute, Kansas City. 833-602-2368
Ulcerative colitis study of tirzepatide
Where: St Louis
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with ulcerative colitis calm gut inflammation.
Free to join
Who can join: Adults 18 to 70 with ulcerative colitis, BMI 27+.
Study record on ClinicalTrials.gov
Washington University School of Medicine, St Louis
Show 8 more studies
Crohn's disease study of tirzepatide
Where: St Louis
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with Crohn's disease calm gut inflammation.
Free to join
Who can join: Adults 18 to 70 with Crohn's disease, BMI 27+.
Study record on ClinicalTrials.gov
Washington University School of Medicine, St Louis
Fatty liver disease (MASLD) study of retatrutide
Where: Kansas City
What: Tests whether a GLP-1, GIP and glucagon medicine from Lilly, retatrutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (MASLD), BMI 25+.
Study record on ClinicalTrials.gov
AMR Clinical, Kansas City
Prehypertension study of orforglipron
Where: Springfield
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people with prediabetes lose weight.
Free to join
Who can join: Adults 18+ who are overweight, BMI 25+.
Call the site: 417-883-7889Study record on ClinicalTrials.gov
Clinvest Headlands Llc, Springfield. 417-883-7889
ASCVD study of semaglutide
Where: Columbia
What: Tests whether a GLP-1 medicine, semaglutide, can help people lower blood sugar.
Free to join
Who can join: Adults 40 to 80 with type 2 diabetes.
Call the site: 833-970-0046Study record on ClinicalTrials.gov
University of Missouri-Columbia, Columbia. 833-970-0046
Hypertension study
Where: Columbia
What: Tests whether a GLP-1 medicine can help people with obesity lose weight.
Free to join
Who can join: Adults 18+ with obesity, BMI 30+.
Call the site: 573-882-5609Study record on ClinicalTrials.gov
University of Missouri Hospital, Columbia. 573-882-5609
Opioid use disorder study of tirzepatide
Where: Cape Girardeau
What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people with opioid use disorder cut down on opioids.
Free to join
Who can join: Adults 18+ with opioid use disorder, BMI 23+.
Call the site: 573-803-4158Study record on ClinicalTrials.gov
The Gibson Center for Behavioral Change, Cape Girardeau. 573-803-4158
Chronic kidney disease study of NNC0519-0130
Where: Kansas City
What: Tests whether an investigational medicine from Novo Nordisk, NNC0519-0130, can help people with chronic kidney disease protect their kidneys.
Free to join
Who can join: Adults 18+ with chronic kidney disease, BMI 27+.
Study record on ClinicalTrials.gov
Clinical Research Consultants, Kansas City
Crohn's disease study of tirzepatide
Where: St Louis
What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people with Crohn's disease calm gut inflammation.
Free to join
Who can join: Adults 18 to 80 with Crohn's disease, BMI 25+.
Call the site: 314-362-9044Study record on ClinicalTrials.gov
Washington University School of Medicine, St Louis. 314-362-9044
Source: ClinicalTrials.gov, the federal registry, read October 16, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.
Clinical trials by state
Every state with a GLP-1 study recruiting today. 48 of them.
- Alabama (18)
- Arizona (22)
- Arkansas (5)
- California (53)
- Colorado (18)
- Connecticut (14)
- Delaware (1)
- District of Columbia (1)
- Florida (43)
- Georgia (23)
- Hawaii (6)
- Idaho (12)
- Illinois (30)
- Indiana (20)
- Iowa (10)
- Kansas (14)
- Kentucky (18)
- Louisiana (14)
- Maine (1)
- Maryland (25)
- Massachusetts (20)
- Michigan (21)
- Minnesota (19)
- Mississippi (7)
- Missouri (22)
- Montana (3)
- Nebraska (7)
- Nevada (11)
- New Hampshire (3)
- New Jersey (11)
- New Mexico (5)
- New York (30)
- North Carolina (31)
- North Dakota (5)
- Ohio (31)
- Oklahoma (12)
- Oregon (5)
- Pennsylvania (33)
- Rhode Island (5)
- South Carolina (25)
- South Dakota (2)
- Tennessee (27)
- Texas (56)
- Utah (14)
- Virginia (28)
- Washington (24)
- West Virginia (5)
- Wisconsin (7)